TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Eclipse Biofarm AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
14,465
|
16,061
|
16,884 |
| Financial expenses |
231
|
198
|
63 |
| Earnings before taxes |
-225
|
139
|
1,000 |
| EBITDA |
347
|
602
|
1,301 |
| Total assets |
10,107
|
9,806
|
11,650 |
| Current assets |
7,805
|
7,388
|
9,708 |
| Current liabilities |
6,349
|
5,818
|
7,800 |
| Equity capital |
3,561
|
3,742
|
3,623 |
| - share capital |
200
|
200
|
200 |
| Employees (average) |
5
|
6
|
8 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.2%
|
38.2%
|
31.1% |
| Turnover per employee |
2,893
|
2,677
|
2,110 |
| Profit as a percentage of turnover |
-1.6%
|
0.9%
|
5.9% |
| Return on assets (ROA) |
0.1%
|
3.4%
|
9.1% |
| Current ratio |
122.9%
|
127.0%
|
124.5% |
| Return on equity (ROE) |
-6.3%
|
3.7%
|
27.6% |
| Change turnover |
-1,596
|
-823
|
1,424 |
| Change turnover % |
-10%
|
-5%
|
9% |
| Chg. No. of employees |
-1
|
-2
|
3 |
| Chg. No. of employees % |
-17%
|
-25%
|
60% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.